Esperion Therapeutics (ESPR) Financials

$3.18

$0.00 (0.00%)

As on 15-Jul-2026 09:30EDT

Market cap

$819 Mln

Revenue (TTM)

$418 Mln

P/E Ratio

--

P/B Ratio

98.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	418.24	403.14	332.31	116.33	75.48	78.45
Cost of Revenue	146.39	129.22	68.60	43.27	26.97	14.22
Gross Profit	271.85	273.91	263.71	73.07	48.51	64.23
Operating Expenses	196.07	213.64	209.31	228.63	228.01	290.96
Operating Profit (EBIT)	75.79	60.27	54.40	-155.56	-179.50	-226.73
Other Income	--	--	--	--	2.65	3.98
Profit before Tax	-5.58	-20.84	-51.75	-209.25	-233.66	-269.11
Provision for Tax	1.84	1.84	-51.75	0.00	54.16	49.72
Profit after Tax (Net Income)	-7.42	-22.68	-51.75	-209.25	-233.66	-269.11
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-233.66	-269.11

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	-307.93	-301.97	-388.72	-454.99	-323.78	-196.94
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	470.10	467.04	486.31	504.57	479.41	505.18
Current Liabilities	300.36	300.81	246.23	156.22	92.31	73.35
Total Liabilities	762.89	465.89	343.82	205.80	247.94	381.59

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	3.07	3.32	5.82	4.73	1.26	52.62
Current Assets	459.46	462.57	338.00	201.07	246.68	328.97
Total Assets	762.89	465.89	343.82	205.80	247.94	381.59
Total Debt*	543.81	548.00	591.21	540.95	260.95	260.20
Net Current Assets	159.10	161.76	91.77	44.84	154.38	255.62

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-13.09	-23.65	-135.49	-174.83	-263.81
Cash Flow from Investing Activities	--	0.19	-0.32	42.50	8.10	-50.48
Cash from Financing Activities	--	36.18	86.48	50.46	32.61	268.22
Net Cash Inflow / Outflow	--	--	--	--	-134.12	-46.07

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.11	-0.08	-0.26	-1.86	-3.18	-7.30
Cash EPS ($)	--	-0.08	-0.26	-1.86	-3.17	-7.29
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.05	-0.12	-1.21	-2.38	-7.16
Free Cash Flow per Share ($)	--	-0.05	-0.12	-1.21	-2.38	-7.16

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-10.11	-35.88	-1,809.87	-110,738.86	-352.87
ROE (%)	--	6.57	12.27	53.74	89.74	183.64
ROA (%)	-1.09	-5.60	-18.83	-92.23	-74.23	-73.24
EBIT Margin (%)	9.51	15.82	2.26	-129.17	-234.31	-283.96
Net Margin (%)	-1.77	-5.63	-15.57	-179.87	-299.08	-326.50
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	61.13	0.21	1.86	0.54	-0.04	-0.66
EBIT Growth (%)	144.93	749.49	104.99	15.03	20.61	-84.28
Net Profit Growth (%)	95.16	56.17	75.27	10.45	13.17	-87.47
EPS Growth (%)	86.70	0.70	0.86	0.41	0.56	-0.37
Book Value Growth (%)	43.63	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-46.42	-8.31	-1.61	-1.96	-0.68
Price / Book Value	98.42	-3.49	-1.11	-0.74	-1.41	-0.94
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	11.52	22.44	115.83	-5.29	-3.13	-0.83
Close Price ($)	2.74	3.70	2.20	2.99	6.23	5.00
High Price ($)	4.18	4.13	3.94	7.41	8.87	39.50
Low Price ($)	0.69	0.69	1.58	0.70	3.28	4.70
Market Cap ($ Cr)	819.46	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	-0.81	-1.81	-1.52	-1.19	-0.81	-1.32
Short term debt to equity ratio	-0.27	-0.30	-0.27	-0.08	-0.08	-0.07
Current Ratio	1.53	1.54	1.37	1.29	2.67	4.48
Quick Ratio	1.18	1.19	0.99	0.87	2.29	4.02
Interest Coverage	0.93	0.75	0.13	-2.55	-3.11	-4.81

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	31.64	34.77	24.12	41.69	44.69	29.24
Asset Turnover	0.62	1.00	1.21	0.51	0.24	0.21
Receivable days	--	99.81	70.69	129.08	137.11	82.23
Inventory Days	--	282.10	426.24	425.57	471.31	649.08
Payable days	--	164.95	221.94	231.13	274.94	893.20
Cash Conversion Cycle	--	216.97	275.00	323.52	333.47	-161.89

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.